4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-005600
INTERIM CFO bought 50,000 shares at $0.72 ($36,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffken Daniel E. INTERIM CFO | 2021-11-29 | Purchase | +50,000 | $0.72 | $36,000 | 50,000 | D: show line 1 in the form |
| Open-market purchases · 50,000 sh · avg $0.72 · $36,000 | |||||||
Loading xslF345X03/form4-12012021_081251.xml…